Summary Previous studies have suggested that 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-(2-chloroethyl)-3-nitrosoureahydrochloride (ACNU) and 1,(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) bind specifically to the nucleosomal DNA of murine bone marrow and L1210 leukaemia cells whereas the glucose nitrosoureas, 2-(3-(2-chloroethyl)-3-nitrosoureido)-2-deoxy-D-glucopyranose, (chlorozotocin, CLZ) and 1-(2-chloroethyl)-3-(-D-glucopyranosyl)-l-nitrosourea (GANU), bind preferentially to the linker DNA of bone marrow but not tumour cell chromatin. In order to provide an explanation for this differential, the DNA repeat and linker lengths in murine bone marrow and L1210 leukaemia cells were measured using electrophoresis of micrococcal nuclease-digested DNA. The linker length of bone marrow chromatin was approximately 22% longer than that in L1210 leukaemia cells from mouse ascites. The linker length of L1210 cells maintained in suspension culture was 27% less than in those from ascites fluid. The tissue-specific toxicity of sugar nitrosoureas and the differential binding of these drugs to chromatin does not appear to correlate quantitatively with differences in DNA linker length.
The use of nitrosoureas in cancer chemotherapy has been seriously limited by their acute myelotoxicity, (Wasserman et al., 1975; Osband et al., 1977) . This problem led to the development of the glucosenitrosourea analogues, 2-(3-(2-chloroethyl)-3-nitrosoureido)-2-deoxy-D-glucopyranose, (chlorozotocin, CLZ) and 1-(2-chloroethyl)-3-(-D-glucopyranosyl)-1-nitrosourea (GANU) which were less myelotoxic than the more traditional chloroethylnitrosoureas, 1,(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-(2-chloroethyl)-3-nitrosoureahydrochloride (ACNU) yet retained comparable antitumour activity in experimental tumours as well as in man (Panasci et al., 1977 (Panasci et al., , 1979 Hoth et al., 1980) . Myelosuppression was not correlated with the more usual explanations of alkylating or carbamoylating potential, cellular drug uptake, type of DNA lesion or DNA repair (Vu et al., 1983) . Efforts to determine why the glucose-nitrosoureas were less toxic to bone marrow have considered the binding of drugs to chromatin and chromatin constituents. The nucleosomal core of chromatin consists of histones H2A, H2B, H3 and H4 in the form of a double tetramer (Thomas & Kornberg, 1975) which is highly conserved for many generations during cell proliferation (Gurley & Hardin, 1969; Hancock, 1969) and around which is wound DNA (Thomas & Kornberg, 1975; Worcel & Benyajati, 1977) some 146bp in length (Noll & Kornberg, 1977 (Chambon, 1977) . Histone Hi is often, but not always, present and is thought to stabilize the helical winding of DNA around the core proteins, with additional involvement of non-histone proteins (Noll & Kornberg, 1977) . This repeating nucleosomal structure is found in both transcriptionally active and inactive chromatin although the active regions have been shown to be enriched in non-histone proteins (Gottesfeld & Butler, 1977) . Using radiolabelled drugs, it was found that both GANU and CLZ alkylated the DNA of L1210 leukaemia cells more than that of mouse bone marrow, whereas ACNU and CCNU both preferentially alkylated the DNA of bone marrow (Tew et al., 1978; Green et al., 1982) . Through the use of transcription-promoting agents, such as hydrocortisone, it was discovered that both CLZ and CCNU bound preferentially to transcriptionally active chromatin (Tew et al., 1980) . However, it was necessary to consider a lower order of chromatin organization before differences in binding between myelotoxic and marrow-sparing nitrosoureas began to emerge. Using micrococcal nuclease digestion (Sollner Webb et al., 1978) and DNAse 1 digestion (Billing & Bonner, 1972) , studies using HeLa cells showed that both CLZ and CCNU preferentially alkylated the DNA associated with the core particle (Tew et al., 1978) . It was later shown that ACNU, CCNU, CLZ and GANU all preferentially alkylated the nucleosomal core DNA of chromatin from in vivo L1210 cells (Green et al., 1982) . ACNU and CCNU were more specific for the nucleosomal DNA of mouse bone marrow but the glucose nitrosoureas, CLZ and GANU, bound (Bodell, 1977; Cleaver, 1977; Smerdon et al., 1979 Gels were run for 3 h at room temperature. Electrophoresis overnight or in the cold did not alter resolution. Gels were stained by immersion in 5 jug mlethidium bromide (Sigma) for 15 min, followed by a water wash for 15 min. DNA fluorescence was visualized using a 305 nm UV-light box, then photographed with a Polaroid instant camera. Photographs were scanned using a Quick Scan Jr. scanning densitometer (Helena Labs., Beaumont, TX) and migration of bands measured on the resultant traces. For each gel, calibration curves based on marker DNA migration were constructed and used to calculate the numbers of base pairs in the sample DNA bands.
Results
Figure 1 is an example of a gel on which DNA fragments from micrococcal nuclease-digested nuclei isolated from L1210 leukaemia (cultured and mouse ascites) and from mouse bone marrow cells were all run alongside OX174 HaeIII standard fragments. The enzyme digestion has produced banding patterns, representative of digestion of the chromatin into smaller molecular weights and indicating the presence of nucleosomal monomers (arrowed), dimers, trimers and larger oligomers. Differences are apparent in the distances to which the samples from different cellular origins have migrated. DNA from cultured L1210 cells (b) has migrated fastest and that from mouse bone marrow (c) the slowest. Quantitative values, in terms of length in base pairs (bp), were obtained by averaging the differences between the first (monomer) and next 4-6 bands. This method gives a more accurate measurement of linker length than using the values for the bands themselves as the enzyme trims the cut ends of the polynucleosomes during digestion (Noll & Kornberg, 1977) . Table I shows the repeat lengths for the three cell types The banding patterns derived from electrophoresis of DNA from control and drug-treated, in vitro L1210 cells are shown in Figures 2 and 3 . Treatment for 6 h with 1 mM CCNU (Figure 2 ) has no effect on micrococcal nuclease digestion, neither has treatment for 1 h with 4mM CLZ or 1 mM L-PAM, (Figure 3) . HN2, on the other hand at 1 mM for 1 h caused an increase in the proportion of mononucleosomal and smaller oligomer fractions, as well as a small reduction in the rate of migration, (Figure 3 ).
Discussion
Consistent and reproducible differences have been found in the repeat length of the DNA from bone marrow and L1210 leukaemia cells from mouse ascites. The bone marrow linker region (63 bp) was -22% longer than that in the tumour (51 bp).
Drug binding data shown in Table II suggests that the toxicity of CLZ and, indeed, other chloroethylnitrosoureas, is related to the extent to which (Bodell, 1977; Cleaver, 1977; Smerdon et al., 1979) which would render alkylation in this region less cytotoxic. It is possible that variation in cellular sensitivity to the different types of drug may be a result of differences in the ability of cells to repair drug-induced damage to linker versus nucleosomal DNA.
The observed repeat lengths of cultured L1210 cells and those grown in vitro, 186 + 5 and 197+4bp respectively, are in approximate accordance with a report that cells in culture generally have a repeat length of less than 196 bp (Compton et al., 1976) . It was also suggested that increased repeat length may correspond to increased cell growth and genetic activity. Murine bone marrow consists of a variety of cell types, varying in proliferative status from pluripotential stem cells to mature blood cells (Tavassoli & Yoffey, 1983) and it is estimated that only about 1 in 104 represent the colony forming units (Coggle & Gordon, 1975) , the great majority being mature and hence non-dividing cells. Thus, not only have we observed a consistent and reproducible measurement of repeat length but we have seen a longer repeat length in a population containing a large proportion of non-dividing cells compared to both L1210 populations which were maintained in exponential growth.
It is also important to note that neither CCNU nor CLZ had any measurable effect on the digestion of L1210 DNA by micrococcal nuclease. This observation serves to validate previous studies which used micrococcal nuclease digestion of nitrosourea-treated chromatin (Tew et al., 1978 , Green et al., 1982 . The alteration of the digestion pattern seen after treatment with HN2 would advise caution if the site of binding of this drug were to be investigated by following the micrococcal nuclease-induced release of HN2 from treated chromatin.
In conclusion, a 22% longer DNA linker length in murine bone marrow cannot account quantitatively for the reported 2-4 fold increased binding of sugar nitrosoureas to linker DNA (Green et al., 1982) . The effective specificity of sugar nitrosoureas for tumour cells and their reduced myelotoxicity may lie in other structural or conformational differences in the chromatin and associated proteins in these two cell types. This investigation was supported by NIH grant CA17583 and ACS grant CH-13f.
